[-2]proPSA improves prostate cancer detection: An EDRN validation study

被引:0
|
作者
Sokoll, Lori J. [1 ]
Wang, Yinghui [2 ]
Feng, Ziding [2 ]
Kagan, Jacob [3 ]
Partin, Alan W. [1 ]
Sanda, Martin G. [4 ]
Thompson, Ian M. [5 ]
Chan, Daniel W. [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Natl Canc Inst, Bethesda, MD USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:135 / 135
页数:1
相关论文
共 50 条
  • [21] Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer
    Lamy, Pierre-Jean
    Montels, Frederic
    Tosi, Diego
    Leizour, Benoit
    Bascoul-Mollevi, Caroline
    Castan, Florence
    Roques, Sylvie
    Nielloud, Fabien
    Rebillard, Xavier
    ANNALES DE BIOLOGIE CLINIQUE, 2013, 71 (05) : 537 - 544
  • [22] Early Detection Research Network (EDRN) validation of circulating ovarian cancer biomarkers
    Skates, Steven J.
    Anderson, Karen S.
    Liu, Tao
    Kulasingam, Vathany
    Rabideau, Dustin
    Wu, Chaochao
    Gillette, Michael
    Godwin, Andrew K.
    Urban, Nicole
    Lokshin, Anna
    Marks, Jeffrey
    Diamandis, Eleftherios
    Zhang, Zhen
    Srivastava, Sudhir
    Kagan, Jacob
    Patriotis, Christos
    Rodland, Karin
    CANCER RESEARCH, 2015, 75
  • [23] Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
    Filella, Xavier
    Gimenez, Nuria
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (04) : 729 - 739
  • [24] Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study
    Park, Hongzoo
    Lee, Sang Wook
    Song, Geehyun
    Kang, Tae Wook
    Jung, Jae Hung
    Chung, Hyun Chul
    Kim, Sung Jin
    Park, Chang-Hoo
    Park, Jong Yeon
    Shin, Tae Young
    Suh, In Bum
    Kim, Jeong Hyun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (11)
  • [25] The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis
    Osredkar, Josko
    Kumer, Kristina
    Fabjan, Teja
    Hlebic, Gregor
    Podnar, Blaze
    Lenart, Gordan
    Smrkolj, Tomaz
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2016, 40 (06): : 419 - 424
  • [26] Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer
    Huang, Ya-Qiang
    Sun, Tong
    Zhong, Wei-De
    Wu, Chin-Lee
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2014, 2 (04): : 343 - 350
  • [27] [-2]proenzyme prostate specific antigen for prostate cancer detection: A National Cancer Institute Early Detection Research Network validation study
    Sokoll, Lori J.
    Wang, Yinghui
    Feng, Ziding
    Kagan, Jacob
    Partin, Alan W.
    Sanda, Martin G.
    Thompson, Ian M.
    Chan, Daniel W.
    JOURNAL OF UROLOGY, 2008, 180 (02): : 539 - 543
  • [28] A [-2]proPSA-Based Artificial Neural Network Significantly Improves Differentiation Between Prostate Cancer and Benign Prostatic Diseases
    Stephan, Carsten
    Kahrs, Anna-Maria
    Cammann, Henning
    Lein, Michael
    Schrader, Mark
    Deger, Serdar
    Miller, Kurt
    Jung, Klaus
    PROSTATE, 2009, 69 (02): : 198 - 207
  • [29] [-2]pro PSA Significantly Improves Prostate Cancer Detection
    Stephan, Carsten
    Kahrs, Anna-Maria
    Cammann, Henning
    Miller, Kurt
    Lein, Michael
    TUMOR BIOLOGY, 2008, 29 : 54 - 54
  • [30] NCI-EDRN validation of salivary oral cancer biomarkers
    Wong, D. T.
    Wang, J.
    Reiss, J.
    Zimmermann, B.
    Zhou, H.
    Elashoff, D.
    Morris, D.
    Randolph, T.
    Feng, Z.
    Chia, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)